✦ LIBER ✦

PCV57 Cost-Effectiveness of Rivaroxaban Compared with Warfarin for Stroke Prevention in Atrial Fibrillation

✍ Scribed by A.K. Kapur; I. Chatzitheofilou; L.K. Schang

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost–Effectiveness of Rivaroxaban Compar

✍ Soyon Lee; Moise W. Anglade; Dan Pham; Robyn Pisacane; Jeffrey Kluger; Craig I. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 786 KB

COST-EFFECTIVENESS OF RIVAROXABAN COMPAR

✍ Soyon Lee; Moise Anglade; Robyn Pisacane; Dan Pham; Jeffrey Kluger; Craig Colema 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB

PCV73 Prevention of Stroke in Patients W

✍ M. Psenkova; M. Lukac; S. Mackovicova; M. Stachova; J. Bielik; G.A. Pietsch; Y. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PCV54 Cost-Effectiveness Analysis of Dab

✍ M.A. Ward; A.K. Biddle 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PCV50 COST-EFFECTIVENESS ANALYSIS COMPAR

✍ Y. Zhao; L. Lim; C.I. Coleman 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Cost-effectiveness of apixaban vs warfar

✍ Kamel, H.; Easton, J. D.; Johnston, S. C.; Kim, A. S. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 578 KB